The later part of the 20th Century and the first two decades of the 21st century have seen the medical community intensify their research on cancer and attempts to get a cure or therapies that can better deal with the different types of tumors. One of the suggested areas that are receiving attention includes the study into stem cells and the relationship between aging of the body cells and the development of cancer. One scientist that has been studying cancer and aging is Mikhail Blagosklonny. He is a professor of oncology at the Roswell Park Cancer Institute in New York.
Mikhail Blagosklonny studied medicine and acquired his M.D and PhD in medicine and cardiology from The First Pavlov State Medical University in St. Petersburg. After his studied, he was appointed to the post of associate professor at the New York Medical College. He then proceeded to take up a position as a researcher at the Ordway Research Institute in Albany, NY. In 2008, he got a position at the Roswell Park Cancer Institute. The studies that he takes part in include looking into the causes of cancer and the therapies that help protect normal cells from the damages that are caused by cancer.
The researcher came up with a formulation that states that TOR signaling might enable reduce cancer and aging. According to him, Rampamycin, which is a popular cancer drug can be used on patients suffering from cancer to prolong their lives. He is one of the most passionate advocates for the use of the drug in the therapy. In addition to his contributions towards this research, he has also published widely on the same subject and other medical related subjects. He is an editor of magazines such as aging, cell cycle and also Oncotarget. He is also a member of the Editorial board of the Cell Death and Differentiation. He has more than 30 publications to his name and is still working on others.
Mikhail Blagosklonny states that his main goal is to see to it that human life is extended through the use of the right therapies.